EGFR and breast carcinoma: Interestingly, EGFR inhibitor AG-1478 also blocked the upregulation of TAZ mRNA level, but EGF treatment couldn't induce TAZ expression (Figure S1D), implicating a heterodimer of ERBB mediating the function of HRG1 in activating TAZ expression in breast cancer cells.